Omer Onder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Omer Onder has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Gamze Durhan
Department of Radiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye
3 shared publications - Ali Devrim Karaosmanoglu
Department of Radiology, Hacettepe University School of Medicine, Ankara, Turkey
2 shared publications - Aynur Azizova
Amsterdam UMC location Vrije Universiteit Amsterdam, Radiology & Nuclear Medicine Department, Amsterdam, Netherlands
2 shared publications - Deniz Akata
Department of Radiology, Hacettepe University School of Medicine, Ankara, Turkey
2 shared publications - Emrah Duman
Department of Radiology, Division of Cardiothoracic Imaging, University of Pittsburgh Medical Center, 203 Lothrop St, EEI Ste 700, Pittsburgh, PA 15213
2 shared publications - Figen Basaran Demirkazik
Department of Radiology, Hacettepe University School of Medicine, Ankara, Turkey
2 shared publications
Latest Publications
- 1 June 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (6) , e250052
Cardiac MRI in Depiction of Myocardial Edema: A Comprehensive Review
Cardiac MRI techniques are vital for assessing myocardial edema, offering key insights into disease activity, progression, and prognosis, and—when optimized for artifacts and integrated with the clinical context—can enhance diagnostic accuracy and guide patient management across a range of cardiovascular conditions.
- 1 June 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (6) , e250052
Cardiac MRI in Depiction of Myocardial Edema: A Comprehensive Review
Cardiac MRI techniques are vital for assessing myocardial edema, offering key insights into disease activity, progression, and prognosis, and—when optimized for artifacts and integrated with the clinical context—can enhance diagnostic accuracy and guide patient management across a range of cardiovascular conditions.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (5) , e250100
Understanding Adenocarcinoma of the Lung Developing from Subsolid Nodules and Atypical Pulmonary Cysts
Subsolid nodules and atypical pulmonary cysts can pose diagnostic challenges due to their slow growth and atypical imaging features, and improved understanding of their imaging hallmarks, pathologic correlations, guideline-based recommendations, and risk assessment strategies is essential for accurately identifying pulmonary adenocarcinomas that may arise from these potentially malignant lesions.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (5) , e250100
Understanding Adenocarcinoma of the Lung Developing from Subsolid Nodules and Atypical Pulmonary Cysts
Subsolid nodules and atypical pulmonary cysts can pose diagnostic challenges due to their slow growth and atypical imaging features, and improved understanding of their imaging hallmarks, pathologic correlations, guideline-based recommendations, and risk assessment strategies is essential for accurately identifying pulmonary adenocarcinomas that may arise from these potentially malignant lesions.
- Open Access
- 1 May 2024
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 30 (3) , 139-151
Long-term follow-up results of multiparametric prostate MRI and the prognostic value of PI-RADS: a single-center retrospective cohort study
We aim to examine the long-term outcomes of patients who underwent multiparametric prostate magnetic resonance imaging (mp-MRI) for suspected prostate cancer (PCa), specifically based on their initial Prostate Imaging Reporting and Data System (PI-RADS) categories and various clinical factors. Our secondary aim is to evaluate the prognostic value of the PI-RADS through the National Comprehensive Cancer Network (NCCN) risk group distribution. This research was conducted as a single-center retrospective cohort study in a tertiary care hospital. A total of 1,359 cases having at least one histopathological examination after the initial mp-MRI and/or adequate clinical/radiological follow-up data were included in the clinically significant PCa (cs-PCa) diagnosis-free survival analysis. Initial mp-MRI dates were accepted as the start of follow-up for the time-to-event analysis. The event was defined as cs-PCa diagnosis (International Society of Urological Pathology ≥2). Patients who were not diagnosed with cs-PCa during follow-up were censored according to predefined literature-based criteria at the end of the maximum follow-up duration with no reasonable suspicion of PCa and no biopsy indication. The impact of various factors on survival was assessed using a log-rank test and multivariable Cox regression. Subsequently, 394 cases diagnosed with PCa during follow-up were evaluated, based on initial PI-RADS categories and NCCN risk groups. Three main risk factors for cs-PCa diagnosis during follow-up were an initial PI-RADS 5 category, initial PI-RADS 4 category, and high MRI-defined PSA density (mPSAD), with average hazard ratios of 29.52, 14.46, and 3.12, respectively. The PI-RADS 3 category, advanced age group, and biopsy-naïve status were identified as additional risk factors (hazard ratios: 2.03, 1.54-1.98, and 1.79, respectively). In the PI-RADS 1-2 cohort, 1, 3, and 5-year cs-PCa diagnosis-free survival rates were 99.1%, 96.5%, and 93.8%, respectively. For the PI-RADS 3 cohort, 1, 3, and 5-year cs-PCa diagnosis-free survival rates were 94.9%, 90.9%, and 89.1%, respectively. For the PI-RADS 4 cohort, 1, 3, and 5-year cs-PCa diagnosis-free survival rates were 56.6%, 55.1%, and 55.1%, respectively. These rates were found to all be 24.2% in the PI-RADS 5 cohort. Considering the 394 cases diagnosed with PCa during follow-up, PI-RADS ≥4 cases were more likely to harbor unfavorable PCa compared to PI-RADS ≤3 cases (p < 0.001). In the PI-RADS 3 subgroup analysis, a low mPSAD (2) was found to be a protective prognostic factor against unfavorable PCa (P = 0.005). The PI-RADS category has a significant impact on patient management and provides important diagnostic and prognostic information. Higher initial PI-RADS categories are associated with decreased follow-up losses, a shorter time to PCa diagnosis, increased biopsy rates, a higher likelihood of developing cs-PCa during follow-up, and a worse PCa prognosis. Combining mPSAD with PI-RADS categories could enhance diagnostic stratification in the identification of cs-PCa.
- 1 May 2024
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 30 (3) , 139-151
Open AccessLong-term follow-up results of multiparametric prostate MRI and the prognostic value of PI-RADS: a single-center retrospective cohort study
We aim to examine the long-term outcomes of patients who underwent multiparametric prostate magnetic resonance imaging (mp-MRI) for suspected prostate cancer (PCa), specifically based on their initial Prostate Imaging Reporting and Data System (PI-RADS) categories and various clinical factors. Our secondary aim is to evaluate the prognostic value of the PI-RADS through the National Comprehensive Cancer Network (NCCN) risk group distribution. This research was conducted as a single-center retrospective cohort study in a tertiary care hospital. A total of 1,359 cases having at least one histopathological examination after the initial mp-MRI and/or adequate clinical/radiological follow-up data were included in the clinically significant PCa (cs-PCa) diagnosis-free survival analysis. Initial mp-MRI dates were accepted as the start of follow-up for the time-to-event analysis. The event was defined as cs-PCa diagnosis (International Society of Urological Pathology ≥2). Patients who were not diagnosed with cs-PCa during follow-up were censored according to predefined literature-based criteria at the end of the maximum follow-up duration with no reasonable suspicion of PCa and no biopsy indication. The impact of various factors on survival was assessed using a log-rank test and multivariable Cox regression. Subsequently, 394 cases diagnosed with PCa during follow-up were evaluated, based on initial PI-RADS categories and NCCN risk groups. Three main risk factors for cs-PCa diagnosis during follow-up were an initial PI-RADS 5 category, initial PI-RADS 4 category, and high MRI-defined PSA density (mPSAD), with average hazard ratios of 29.52, 14.46, and 3.12, respectively. The PI-RADS 3 category, advanced age group, and biopsy-naïve status were identified as additional risk factors (hazard ratios: 2.03, 1.54-1.98, and 1.79, respectively). In the PI-RADS 1-2 cohort, 1, 3, and 5-year cs-PCa diagnosis-free survival rates were 99.1%, 96.5%, and 93.8%, respectively. For the PI-RADS 3 cohort, 1, 3, and 5-year cs-PCa diagnosis-free survival rates were 94.9%, 90.9%, and 89.1%, respectively. For the PI-RADS 4 cohort, 1, 3, and 5-year cs-PCa diagnosis-free survival rates were 56.6%, 55.1%, and 55.1%, respectively. These rates were found to all be 24.2% in the PI-RADS 5 cohort. Considering the 394 cases diagnosed with PCa during follow-up, PI-RADS ≥4 cases were more likely to harbor unfavorable PCa compared to PI-RADS ≤3 cases (p < 0.001). In the PI-RADS 3 subgroup analysis, a low mPSAD (2) was found to be a protective prognostic factor against unfavorable PCa (P = 0.005). The PI-RADS category has a significant impact on patient management and provides important diagnostic and prognostic information. Higher initial PI-RADS categories are associated with decreased follow-up losses, a shorter time to PCa diagnosis, increased biopsy rates, a higher likelihood of developing cs-PCa during follow-up, and a worse PCa prognosis. Combining mPSAD with PI-RADS categories could enhance diagnostic stratification in the identification of cs-PCa.
- Open Access
- 1 January 2024
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 30 (1) , 28-29
Centrilobular ground-glass nodule pattern in acute myeloid leukemia patients receiving cytosine arabinoside chemotherapy: an important form of drug-induced lung disease
- 1 January 2024
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 30 (1) , 28-29
Open AccessCentrilobular ground-glass nodule pattern in acute myeloid leukemia patients receiving cytosine arabinoside chemotherapy: an important form of drug-induced lung disease
- 1 December 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 309 (3) , e233091
Four-dimensional Cardiac CT Depicts Coexistent Amyloidosis in Older Adults with Severe Aortic Stenosis
- 1 December 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 309 (3) , e233091
Four-dimensional Cardiac CT Depicts Coexistent Amyloidosis in Older Adults with Severe Aortic Stenosis
- Open Access
- 11 May 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (7) , 2452-2460
Multimodality imaging findings of infected endometriomas: “T1 signal reversal” as a potential diagnostic sign?
- 11 May 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (7) , 2452-2460
Open AccessMultimodality imaging findings of infected endometriomas: “T1 signal reversal” as a potential diagnostic sign?
- Open Access
- 7 July 2021
- Published by Springer Nature in Insights into Imaging
- Vol. 12 (1) , 1-31
Identifying the deceiver: the non-neoplastic mimickers of genital system neoplasms
Tumors of the genital system are common and imaging is of crucial importance for their detection and diagnosis. Several non-neoplastic diseases may mimic these tumors and differential diagnosis may be difficult in certain cases. Misdiagnosing non-neoplastic diseases as tumor may prompt unnecessary medical treatment or surgical interventions. In this article, we aimed to present the imaging characteristics of non-neoplastic diseases of the male and female genital systems that may mimic neoplastic processes. Increasing awareness of the imaging specialists to these entities may have a severe positive impact on the management of these patients.
- 7 July 2021
- Published by Springer Nature in Insights into Imaging
- Vol. 12 (1) , 1-31
Open AccessIdentifying the deceiver: the non-neoplastic mimickers of genital system neoplasms
Tumors of the genital system are common and imaging is of crucial importance for their detection and diagnosis. Several non-neoplastic diseases may mimic these tumors and differential diagnosis may be difficult in certain cases. Misdiagnosing non-neoplastic diseases as tumor may prompt unnecessary medical treatment or surgical interventions. In this article, we aimed to present the imaging characteristics of non-neoplastic diseases of the male and female genital systems that may mimic neoplastic processes. Increasing awareness of the imaging specialists to these entities may have a severe positive impact on the management of these patients.
- 2 July 2019
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 15 (3) , 176-182
Can Radiologist and Pathologist Reach The Truth Together in The Diagnosis of Benign Fibroepithelial Lesions?
Eur J Breast Health AVES | Copyright © 2017 Türkiye Meme Hastalıkları Dernekleri Federasyonu |
- 2 July 2019
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 15 (3) , 176-182
Can Radiologist and Pathologist Reach The Truth Together in The Diagnosis of Benign Fibroepithelial Lesions?
Eur J Breast Health AVES | Copyright © 2017 Türkiye Meme Hastalıkları Dernekleri Federasyonu |
- 2 July 2019
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 15 (3) , 147-152
Imaging Findings and Clinicopathological Correlation of Breast Cancer in Women under 40 Years Old
Eur J Breast Health AVES | Copyright © 2017 Türkiye Meme Hastalıkları Dernekleri Federasyonu |
- 2 July 2019
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 15 (3) , 147-152
Imaging Findings and Clinicopathological Correlation of Breast Cancer in Women under 40 Years Old
Eur J Breast Health AVES | Copyright © 2017 Türkiye Meme Hastalıkları Dernekleri Federasyonu |